MINNEAPOLIS, MN- December 12, 2018 – New research by University of Minnesota scientists has revealed the three-dimensional structure of the DUX4 protein, which is responsible for the disease, facioscapulohumeral muscular… Read More »
DUX4 structure unveiled
“Building the house” for FSHD therapies
Patients who volunteer for research are the keystone of drug development efforts. Without them, the entire edifice built by teams of biologists, chemists, doctors, and other PhDs and MDs, would… Read More »
Follistatin gene therapy strengthens muscle in FSHD mouse model
An experimental gene therapy has been shown to enlarge and strengthen muscles in a mouse model of facioscapulohumeral muscular dystrophy (FSHD). The study was published on November 15 in the… Read More »
Webinar with Stephen Tapscott MD PhD (video)
From our webinar on November 7, 2018. Dr. Tapscott, one of the world’s leading scientists working on the fundamental understanding of FSH muscular dystrophy, updates us on our understanding of… Read More »
High-intensity exercise training in FSHD
by Amanda Hill If you or a loved one is affected by FSHD, or any muscular dystrophy for that matter, chances are that you’ve heard it’s best not to exercise,… Read More »